Vapotherm Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private

"We are excited to continue our partnership with Vapotherm as they progress on their Path to Profitability. This transaction allows the Company to strengthen their balance sheet as they focus on accelerating their revenue momentum," said Anthony Storino, Head of Life Science Finance at SLR Capital Partners. Under the terms of the definitive merger agreement, Vapotherm's stockholders will receive $2.18 in cash for each outstanding share of Company common stock held immediately prior to the effective time of ...